These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2322631)

  • 1. Antiseptal autoantibodies in schizophrenia.
    Knight JG; Knight A; Menkes DB; Mullen PE
    Biol Psychiatry; 1990 Mar; 27(6):681-2. PubMed ID: 2322631
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiseptal brain antibody in IgG of schizophrenic patients.
    Heath RG; McCarron KL; O'Neil CE
    Biol Psychiatry; 1989 Mar; 25(6):725-33. PubMed ID: 2923934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal electroencephalographic changes induced by anti-septal antibodies.
    Garey RE; Heath RG; Harper JW
    Biol Psychiatry; 1974 Feb; 8(1):75-88. PubMed ID: 4815343
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody to discrete areas of the brain in normal individuals and patients with schizophrenia.
    Kelly RH; Ganguli R; Rabin BS
    Biol Psychiatry; 1987 Dec; 22(12):1488-91. PubMed ID: 3676378
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoantibodies against brain septal region antigens specific to unmedicated schizophrenia?
    Knight JG; Knight A; Menkes DB; Mullen PE
    Biol Psychiatry; 1990 Sep; 28(6):467-74. PubMed ID: 2223917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities of the septum pellucidum in schizophrenia.
    Luauté JP; Sanabria E; Bauge JP; Rodde B
    J Neuropsychiatry Clin Neurosci; 1990; 2(4):461-2. PubMed ID: 2136400
    [No Abstract]   [Full Text] [Related]  

  • 7. Abnormalities of the septum pellucidum in schizophrenia.
    George MS; Scott T; Kellner CH; Malcolm R
    J Neuropsychiatry Clin Neurosci; 1989; 1(4):385-90. PubMed ID: 2521087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors related to the presence of autoantibodies in patients with chronic mental disorders.
    Yannitsi SG; Manoussakis MN; Mavridis AK; Tzioufas AG; Loukas SB; Plataris GK; Liakos AD; Moutsopoulos HM
    Biol Psychiatry; 1990 Apr; 27(7):747-56. PubMed ID: 2328270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CNS antibodies in neurological and psychiatric disorders.
    Anderson NE; Posner JB
    J Neurol Neurosurg Psychiatry; 1988 Jul; 51(7):1009-10. PubMed ID: 3204394
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of anti-Sm antibodies with organic brain syndrome secondary to systemic lupus erythematosus.
    Hirohata S; Kosaka M
    Lancet; 1994 Mar; 343(8900):796. PubMed ID: 7907756
    [No Abstract]   [Full Text] [Related]  

  • 11. Demonstration of nuclear and cytoplasmic fluorescence in brain tissues of schizophrenic and nonschizophrenic patients.
    Boehme DH; Cottrell JC; Dohan FC; Hillegass LM
    Biol Psychiatry; 1974 Feb; 8(1):89-94. PubMed ID: 4205639
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluorescent antibody studies of immunoglobulin binding by brain tissues. Demonstration of cytoplasmic fluorescence by direct and indirect testing in schizophrenic and nonschizophrenic subjects.
    Boehme DH; Cottrell JC; Dohan FC; Hillegass LM
    Arch Gen Psychiatry; 1973 Feb; 28(2):202-7. PubMed ID: 4119296
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibrain antibodies in alcoholic patients.
    Henneberg AE; Böger P; Sahnwaldt F; Dumke HO; Kornhuber HH
    Alcohol Alcohol; 1993 Mar; 28(2):181-7. PubMed ID: 8517889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI of corpus callosum and septum pellucidum in depression.
    Lammers CH; Doraiswamy PM; Husain MM; Figiel GS; Lurie SN; Boyko OB; Ellinwood EH; Nemeroff CB; Krishnan KR
    Biol Psychiatry; 1991 Feb; 29(3):300-1. PubMed ID: 2015336
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical correlates of enlarged cavum septum pellucidum in schizophrenia: A revisit through computed tomography.
    Srivastava NK; Khanra S; Chail V; Khess CR
    Asian J Psychiatr; 2015 Jun; 15():21-4. PubMed ID: 26001900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Incomplete anti-tissue autoantibodies in schizophrenia].
    Gurevich ZP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(11):1683-7. PubMed ID: 5369970
    [No Abstract]   [Full Text] [Related]  

  • 17. Natural autoantibodies in schizophrenia.
    Galinowski A; Barbouche R; Truffinet P; Louzir H; Poirier MF; Bouvet O; Loo H; Avrameas S
    Acta Psychiatr Scand; 1992 Mar; 85(3):240-2. PubMed ID: 1561897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-somatostatin autoantibodies in the blood serum of patients with schizophrenia].
    Rogaeva EA; Chumakova MM; Dergunova NN; Pozharitskaia DA; Kopeĭko GI; Tsutsul'kovskaia MIa; Tsibezov VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(7):82-4. PubMed ID: 1979460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Various patterns in the appearance of anti-brain antibodies in the serum of schizophrenia patients].
    Koliaskina GI; Kushner SG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(11):1679-83. PubMed ID: 5369969
    [No Abstract]   [Full Text] [Related]  

  • 20. Towards a new classification of stable phase schizophrenia into major and simple neuro-cognitive psychosis: Results of unsupervised machine learning analysis.
    Kanchanatawan B; Sriswasdi S; Thika S; Stoyanov D; Sirivichayakul S; Carvalho AF; Geffard M; Maes M
    J Eval Clin Pract; 2018 Aug; 24(4):879-891. PubMed ID: 29790237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.